Biosimilar development process

Biosimilar medicines represent an important advancement in healthcare, offering greater patient access to biological therapies that might otherwise be cost-prohibitive. The biosimilar development process revolves around a comprehensive comparability assessment between the proposed biosimilar and its reference biological product. The primary goal of the development process isn’t to establish the efficacy and safety of the […]

Biosimilars manufacturing excellence

Discover how supplementing CHO cell cultures with high-quality Recombinant Insulin can improve and stabilize cell culture performance—ultimately driving higher monoclonal antibody (mAb) yields and lowering production costs.

Advancing biologics manufacturing 

Optimize biologics manufacturing with Recombinant Insulin—enhancing cell growth, yield, and process consistency for therapeutic production.

The cost-saving impact of Recombinant Insulin

Insulin infographics The cost-saving impact of Recombinant Insulin Solutions Realizing economic returns through improved productivity Explore the infographic below to see how the improved process performance achieved with Recombinant Insulin in cell culture, can translate into impressive cost savings for mAb production at both small and large production scales.  Download the infographic in PDF format […]

Safety Data Sheets for Recombinant Insulin

Safety Data Sheets SDS for Recombinant Insulin Resources You can download our Safety Data Sheets (SDS) for Recombinant Insulin using the links below. These documents are created in accordance with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) as outlined by the United Nations. These SDS documents are essential for downstream users, […]